Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Essa Pharma (EPIX)

Essa Pharma (EPIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 83,007
  • Shares Outstanding, K 44,389
  • Annual Sales, $ 0 K
  • Annual Income, $ -28,540 K
  • EBIT $ -33 M
  • EBITDA $ -33 M
  • 60-Month Beta 1.56
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 0.73

Options Overview Details

View History
  • Implied Volatility 744.09% ( +396.99%)
  • Historical Volatility 31.17%
  • IV Percentile 99%
  • IV Rank 100.00%
  • IV High 744.09% on 07/16/25
  • IV Low 43.38% on 09/11/24
  • Put/Call Vol Ratio 1.33
  • Today's Volume 35
  • Volume Avg (30-Day) 99
  • Put/Call OI Ratio 0.27
  • Today's Open Interest 12,826
  • Open Int (30-Day) 13,331

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/25
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -0.16
  • Growth Rate Est. (year over year) +624,475.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.6606 +12.61%
on 06/18/25
1.8800 -0.53%
on 07/14/25
+0.1800 (+10.65%)
since 06/17/25
3-Month
1.6000 +16.87%
on 05/27/25
1.9050 -1.84%
on 04/24/25
+0.0800 (+4.47%)
since 04/17/25
52-Week
1.4000 +33.57%
on 11/01/24
7.8800 -76.27%
on 09/16/24
-3.8300 (-67.19%)
since 07/17/24

Most Recent Stories

More News
ESSA Pharma Inc. Announces Definitive Agreement to be Acquired by XenoTherapeutics, Inc., Backed by XOMA Royalty Corporation in All-Cash Transaction

/CNW/ -- ESSA Pharma Inc. ("ESSA," or the "Company") (NASDAQ: EPIX) today announced that it has entered into a definitive agreement (the "Business Combination...

XOMA : 26.30 (-1.16%)
EPIX : 1.8700 (+0.54%)
ESSA Pharma: Fiscal Q2 Earnings Snapshot

ESSA Pharma: Fiscal Q2 Earnings Snapshot

EPIX : 1.8700 (+0.54%)
ESSA Pharma Reports Financial Results for Fiscal Second Quarter Ended March 31, 2025

/CNW/ - ESSA Pharma Inc. ("ESSA," or the "Company") (NASDAQ: EPIX), a pharmaceutical company that, prior to the discontinuation of its clinical trials and...

EPIX : 1.8700 (+0.54%)
ESSA PHARMA INC. REPORTS RESULTS OF ANNUAL GENERAL MEETING OF SHAREHOLDERS

/CNW/ - ESSA Pharma Inc. ("ESSA" or the "Company") (NASDAQ: EPIX), a pharmaceutical company that, prior to the discontinuation of its clinical trials and...

EPIX : 1.8700 (+0.54%)
ESSA Pharma: Fiscal Q1 Earnings Snapshot

ESSA Pharma: Fiscal Q1 Earnings Snapshot

EPIX : 1.8700 (+0.54%)
ESSA Pharma Reports Financial Results for Fiscal First Quarter Ended December 31, 2024

/CNW/ - ESSA Pharma Inc. ("ESSA," or the "Company") (NASDAQ: EPIX), a pharmaceutical company that, prior to the discontinuation of its clinical trials and...

EPIX : 1.8700 (+0.54%)
ESSA Pharma: Fiscal Q4 Earnings Snapshot

ESSA Pharma: Fiscal Q4 Earnings Snapshot

EPIX : 1.8700 (+0.54%)
ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Fourth Quarter and Year Ended September 30, 2024

/CNW/ - ESSA Pharma Inc. ("ESSA," or the "Company") (NASDAQ: EPIX), a clinical-stage pharmaceutical company that, prior to the discontinuation of its clinical...

EPIX : 1.8700 (+0.54%)
ESSA Pharma Announces Termination of Phase 2 Study Evaluating Masofaniten Combined with Enzalutamide in Patients with Metastatic Castration-Resistant Prostate Cancer

Efficacy signals observed will not achieve ESSA's target product profile in patients with metastatic castration-resistant prostate cancer naïve to...

EPIX : 1.8700 (+0.54%)
ESSA Pharma Presents Updated Phase 1/2 Masofaniten (EPI-7386) Clinical Data at the 2024 ESMO Congress

Combination of masofaniten plus enzalutamide continues to be well tolerated with durable reductions in PSA in patients with mCRPC Phase 2 dose expansion...

EPIX : 1.8700 (+0.54%)

Business Summary

ESSA Pharma Inc. is a pharmaceutical company. The company focused on the development of small molecule drugs for the treatment of cancer, with focus on advanced prostate cancer. ESSA Pharma Inc. is based in Vancouver, Canada.

See More

Key Turning Points

3rd Resistance Point 1.8833
2nd Resistance Point 1.8767
1st Resistance Point 1.8733
Last Price 1.8700
1st Support Level 1.8633
2nd Support Level 1.8567
3rd Support Level 1.8533

See More

52-Week High 7.8800
Fibonacci 61.8% 5.4046
Fibonacci 50% 4.6400
Fibonacci 38.2% 3.8754
Last Price 1.8700
52-Week Low 1.4000

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar